Skip to main content
NCBI home page
Molecular Cancer logoLink to Molecular Cancer
. 2026 Jul 3;25:162. doi: 10.1186/s12943-026-02700-y

Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment

Zhenyun Yang 1,2,3,#, Xin Wang 1,2,3,#, Yizhen Fu 1,2,3,#, Weijie Wu 1,2,3,#, Zili Hu 1,2,3, Qingyang Lin 1,2,3, Wei Peng 1,2,3, Yangxun Pan 1,2,3, Juncheng Wang 1,2,3, Jinbin Chen 1,2,3, Dandan Hu 1,2,3, Zhongguo Zhou 1,2,3, Li Xu 1,2,3, Yaojun Zhang 1,2,3, Jiajie Hou 4,5,✉, Minshan Chen 1,2,3,✉
PMCID: PMC13330359  PMID: 42400008

Correction: Mol Cancer 23, 186 (2024)

https://doi.org/10.1186/s12943-024-02097-6

Following the publication of the original article [1], upon re-examining the manuscript, the authors regret to inform that an error has been identified in Supplementary Figure 6f. The issue arises from an inadvertent oversight during figure preparation. Specifically, the image for AML12-shYTHDF2_1 and AML12-shYTHDF2_2 was mistakenly substituted. The correct version of Supplementary Material 6 is provided below.

Correct version of Supplementary Material 6:

Supplementary Information

Supplementary Material 6. (12.7MB, pdf)

Footnotes

Zhenyun Yang, Xin Wang, Yizhen Fu and Weijie Wu contributed equally to this work.

Contributor Information

Jiajie Hou, Email: jiajiehou@um.edu.mo.

Minshan Chen, Email: chenmsh@sysucc.org.cn.

Reference

  • 1.Yang Z, Wang X, Fu Y, et al. YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment. Mol Cancer. 2024;23(1):186. 10.1186/s12943-024-02097-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 6. (12.7MB, pdf)

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES